accuRate Evaluation of Benefit With Optimal Medical Treatment With or Without Transcatheter Valve Repair of PARADOXical Low Flow Low Gradient Aortic Stenosis

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 120 participants.

Also called NCT03863132

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 120 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03863132
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Germany, Italy, Switzerland (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT03863132. Randomized; no masking; primary purpose treatment. Start 2019-07-03 (actual); primary completion 2027-09-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
accuRate Evaluation of Benefit With Optimal Medical Treatment With or Without Transcatheter Valve Repair of PARADOXical Low Flow Low Gradient Aortic Stenosis
Acronym
REBOOT-PARADOX
Condition
Aortic Valve Stenosis
Lead sponsor
IHF GmbH - Institut für Herzinfarktforschung (class: other)
Collaborator
Boston Scientific Corporation (class: industry)
Collaborator
Yale University (class: other)

Record details

Record id
cardio:ct-nct03863132
Content hash
0cbca1976e9d548808ad5d06d9361781c7930d0b6b897c73ff6b697cfb0a7fdb